Navigation Links
Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
Date:1/28/2013

TARRYTOWN, N.Y., Jan. 28, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2012 financial and operating results on Thursday, February 14, 2013, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webcast at 8:30 AM EST that day.

Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International).  A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com.  A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days. 

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, and asthma.  For additional information about the company, please visit www.regeneron.com.Contact Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914-847-7799

914.847.764michael.aberman@regeneron.com

peter.dworkin@regeneron.com 


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
3. Regeneron Announces June 2012 Investor Conference Presentations
4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
5. Regeneron Announces September 2012 Investor Conference Presentations
6. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
7. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
8. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
9. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
10. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Atossa Genetics, Inc. (NASDAQ: ATOS ), ... Guse , Chief Financial Officer & General Counsel, will ... Thursday, May 30, 2013, in New York City ... The Company,s presentation is scheduled to begin at 3:30 p.m. ... access the webcast, go to www.atossagenetics.com . ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... Inc. (ERT), (Nasdaq: ERT ) a ... devices to biopharmaceutical and healthcare organizations and the market ... services in drug development, announced today results for ... otherwise noted, all comparative numbers refer to changes ...
... MOUNTAIN VIEW, Calif., Oct. 27, 2011 IRIDEX Corporation (NASDAQ: ... quarter 2011 financial results after the market closes on ... the Company will host a conference call with the investment community ... Thursday, November 3, 2011 to discuss the results ...
Cached Medicine Technology:ERT Reports Third Quarter 2011 Operating Results 2ERT Reports Third Quarter 2011 Operating Results 3ERT Reports Third Quarter 2011 Operating Results 4ERT Reports Third Quarter 2011 Operating Results 5ERT Reports Third Quarter 2011 Operating Results 6ERT Reports Third Quarter 2011 Operating Results 7ERT Reports Third Quarter 2011 Operating Results 8ERT Reports Third Quarter 2011 Operating Results 9ERT Reports Third Quarter 2011 Operating Results 10ERT Reports Third Quarter 2011 Operating Results 11ERT Reports Third Quarter 2011 Operating Results 12ERT Reports Third Quarter 2011 Operating Results 13
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease ... gums and increase the chance of a healthier smile. ... Procedure (LANAP) not only removes diseased gum tissue in patients, ... bone for dental implants. , LANAP uses a ... can also help stimulate the healthy tissue as well as ...
(Date:5/19/2013)... Los Angeles (PRWEB) May 19, 2013 Yeast ... infections can appear in sensitive areas of the human body. ... by Yeastrol. This new formula provides a unique method of ... This new spray solution is now provided to men and ... Yeast is naturally absorbed in the body through food and ...
(Date:5/19/2013)... Passages Malibu, the leading non-12 step, holistic, and ... the launch of a “Sobriety, Health, and Wellness” survey ... “We are always looking for new ways to engage ... regarding sobriety, what’s working for people, and what isn’t,” ... Passages Addiction Treatment Centers located in Malibu and ...
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2
... R.I. March 7, 2011 For those of us living ... period might seem like a vacation. But for those who are ... professor of nursing at the University of Rhode Island, realized that ... The actual idea was inspired by Burbank,s own aunt, a 97-year-old ...
... A summary paper on the effects of alcohol consumption ... an excellent review of a large number of intervention ... the results are presented in a very clear fashion, ... effects of alcohol and polyphenols on risk factors. ...
... very best way of preventing teenagers from consuming large quantities ... and have access to alcohol from their parents, for ... at greater risk of becoming binge drinkers in their late ... "Initiatives that focus on strengthening the parent-child relationship and ...
... Amman, March 7, 2011 Elsevier, the leading ... and services, announced today it has begun offering Arabic ... universities in the Middle East. The first order was ... initiative is one of Elsevier,s many meant to help ...
... BEER-SHEVA, ISRAEL, March 7, 2011 Elderly drivers are half ... a limited field of view, and compensate in part by ... of the Negev (BGU) researchers. In the online ... compared reaction times and perception of pedestrians as hazards between ...
... the most aggressive tumors affecting humans. Multiple alterations in genes ... A new study reveals new molecular insight into the understanding ... a genetic locus -- a piece of DNA with one ... gene or DNA sequence on a chromosome -- called INK4a/ARF ...
Cached Medicine News:Health News:Nursing, engineering professors developing device to get seniors moving 2Health News:Nursing, engineering professors developing device to get seniors moving 3Health News:Effects of alcohol on risk factors for cardiovascular disease 2Health News:Effects of alcohol on risk factors for cardiovascular disease 3Health News:Effects of alcohol on risk factors for cardiovascular disease 4Health News:Effects of alcohol on risk factors for cardiovascular disease 5Health News:Parents important for keeping adolescents off alcohol 2Health News:Elderly see pedestrians half as often as younger drivers, according to Ben-Gurion U. researchers 2Health News:2 proteins play key roles in Burkitt's lymphoma 2
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: